Kim Myeong-Kyu, Lee Seung-Han, Park Man-Seok, Kim Byeong-Chae, Cho Ki-Hyun, Lee Min-Cheol, Kim Jin-Hee, Kim Seung-Min
Department of Neurology, Chonnam National University Medical School, Gwangju 501-190, South Korea.
Neuromuscul Disord. 2004 Nov;14(11):727-31. doi: 10.1016/j.nmd.2004.07.005.
Familial hypokalemic periodic paralysis is an autosomal-dominant disorder with features of both genetic and phenotypic heterogeneity. Mutation screening was performed on Korean hypokalemic periodic paralysis patients to locate the corresponding mutations and to specify the clinical features associated with the mutations. Target-exon PCR, direct sequencing, and restriction fragment length polymorphism analysis were used. A novel SCN4A Arg672Cys mutation and a known CACNL1A3 Arg528His mutation were identified. Incomplete penetrance in women with Arg672Cys mutation was evident. A comparison of the present study with previous studies raises the possibility that hypokalemic periodic paralysis is an allelic-specific or mulfactorial, rather than a gene-specific, disorder. Reported herein are two Korean hypokalemic periodic paralysis families, one carrying a novel SCN4A Arg672Cys mutation with incomplete penetrance in women, and the other carrying a CACNL1A3 Arg528His mutation, with the onset of characteristics of hypoPP developing at an earlier age, as well as a higher penetrance rate in women.
家族性低钾性周期性麻痹是一种常染色体显性疾病,具有遗传和表型异质性特征。对韩国低钾性周期性麻痹患者进行了突变筛查,以定位相应突变并明确与这些突变相关的临床特征。采用了目标外显子聚合酶链反应、直接测序和限制性片段长度多态性分析。鉴定出一种新的SCN4A基因第672位密码子由精氨酸突变为半胱氨酸的突变以及一种已知的CACNL1A3基因第528位密码子由精氨酸突变为组氨酸的突变。携带第672位密码子由精氨酸突变为半胱氨酸突变的女性存在不完全外显现象。本研究与既往研究的比较提示,低钾性周期性麻痹可能是一种等位基因特异性或多因素疾病,而非基因特异性疾病。本文报道了两个韩国低钾性周期性麻痹家系,一个携带新的SCN4A基因第672位密码子由精氨酸突变为半胱氨酸的突变且女性存在不完全外显现象,另一个携带CACNL1A3基因第528位密码子由精氨酸突变为组氨酸的突变,其低钾性周期性麻痹特征的发病年龄较早,且女性的外显率较高。